纯度 | >90%SDS-PAGE. |
种属 | Human |
靶点 | Tet2 |
Uniprot No | Q6N021 |
内毒素 | < 0.01EU/μg |
表达宿主 | E.coli |
表达区间 | 1129-2002aa |
氨基酸序列 | DFPSCRCVEQIIEKDEGPFYTHLGAGPNVAAIREIMEERFGQKGKAIRIERVIYTGKEGKSSQGCPIAKWVVRRSSSEEKLLCLVRERAGHTCEAAVIVILILVWEGIPLSLADKLYSELTETLRKYGTLTNRRCALNEERTCACQGLDPETCGASFSFGCSWSMYYNGCKFARSKIPRKFKLLGDDPKEEEKLESHLQNLSTLMAPTYKKLAPDAYNNQIEYEHRAPECRLGLKEGRPFSGVTACLDFCAHAHRDLHNMQNGSTLVCTLTREDNREFGGKPEDEQLHVLPLYKVSDVDEFGSVEAQEEKKRSGAIQVLSSFRRKVRMLAEPVKTCRQRKLEAKKAAAEKLSSLENSSNKNEKEKSAPSRTKQTENASQAKQLAELLRLSGPVMQQSQQPQPLQKQPPQPQQQQRPQQQQPHHPQTESVNSYSASGSTNPYMRRPNPVSPYPNSSHTSDIYGSTSPMNFYSTSSQAAGSYLNSSNPMNPYPGLLNQNTQYPSYQCNGNLSVDNCSPYLGSYSPQSQPMDLYRYPSQDPLSKLSLPPIHTLYQPRFGNSQSFTSKYLGYGNQNMQGDGFSSCTIRPNVHHVGKLPPYPTHEMDGHFMGATSRLPPNLSNPNMDYKNGEHHSPSHIIHNYSAAPGMFNSSLHALHLQNKENDMLSHTANGLSKMLPALNHDRTACVQGGLHKLSDANGQEKQPLALVQGVASGAEDNDEVWSDSEQSFLDPDIGGVAVAPTHGSILIECAKRELHATTPLKNPNRNHPTRISLVFYQHKSMNEPKHGLALWEAKMAEKAREKEEECEKYGPDYVPQKSHGKKVKREPAEPHETSEPTYLRFIKSLAERTMSVTTDSTVTTSPYAFTRVTGPYNRYI |
预测分子量 | 100 kDa |
蛋白标签 | His tag N-Terminus |
缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是3篇关于TET2重组蛋白的经典文献摘要概括:
---
1. **文献名称**:Structural insight into substrate preference for TET-mediated oxidation
**作者**:He, Y. F. et al.
**摘要**:该研究解析了TET2蛋白催化结构域的晶体结构,发现其通过保守的底物结合口袋识别5-甲基胞嘧啶(5mC),并揭示了其催化氧化反应的分子机制,为设计调控TET2活性的工具奠定基础。
---
2. **文献名称**:TET proteins regulate 5-hydroxymethylcytosine dynamics in hematopoietic stem and progenitor cells
**作者**:Ko, M. et al.
**摘要**:通过重组TET2蛋白体外实验,证明其能够将DNA中的5mC转化为5hmC,并揭示TET2缺失导致造血干细胞中5hmC水平下降,进而影响基因表达谱和细胞分化潜能。
---
3. **文献名称**:Reconstitution of TET2 function in murine hematopoietic stem cells
**作者**:Rasmussen, K. D. et al.
**摘要**:研究利用重组TET2蛋白处理小鼠造血干细胞,证明外源性TET2可恢复其DNA去甲基化能力,逆转异常的表观遗传状态,并改善造血分化功能,为TET2相关疾病的治疗提供实验依据。
---
**注**:以上文献发表于《Nature》《Science》及《Cell Reports》等期刊,聚焦于TET2的结构、催化功能及疾病应用。如需具体年份或PMID可进一步补充。
Tet2 (Ten-Eleven Translocation 2) is a member of the TET family of dioxygenases that play a critical role in epigenetic regulation by catalyzing the oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) in DNA. This process initiates DNA demethylation, influencing gene expression patterns essential for cellular differentiation, development, and tumor suppression. Tet2 is particularly vital in hematopoietic systems, where its dysfunction is linked to hematologic malignancies such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Somatic mutations in the TET2 gene are frequently observed in these diseases, highlighting its role as a tumor suppressor.
Recombinant Tet2 protein is engineered for in vitro and in vivo studies to explore its enzymatic activity, epigenetic mechanisms, and therapeutic potential. Produced via expression systems like E. coli or mammalian cells, the recombinant protein retains catalytic activity to modify DNA methylation states. Researchers utilize it to investigate how Tet2-mediated hydroxymethylation regulates stem cell pluripotency, differentiation, and immune responses. It also serves as a tool for screening small molecules targeting TET2-related pathways or restoring its function in disease models.
Studies with recombinant Tet2 have advanced understanding of epigenetic dysregulation in cancer and aging. Its applications extend to developing biomarkers for 5hmC-based diagnostics and novel therapies for epigenetic disorders. Despite progress, challenges remain in stabilizing the protein and mimicking its native interactions. Ongoing research aims to optimize recombinant Tet2 for high-throughput assays and gene-editing technologies, bridging mechanistic insights with clinical translation.
×